Major Depressive Disorder (MDD), also referred to as depression, is a serious medical illness that disrupts a person’s mood, behavior, thought processes, apart from degrading the physical health.
Psychological treatments (also known as talking therapies) have been found to be an effective way to treat depression. This therapy can help patients in changing their thinking patterns and improve coping skills so an individual is better equipped to deal with life’s stresses and conflicts. As well as supporting recovery, psychological therapies can help in stay well by identifying and changing unhelpful thoughts and behavior.
The Major Depressive Disorder market report covers emerging drugs, current treatment practices, Major Depressive Disorder market share of the individual therapies, current and forecasted Major Depressive Disorder Market Size from 2017 to 2030 segmented by seven major markets.
The report also provides detailed current Major Depressive Disorder treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Major Depressive Disorder Market Key Facts
The total prevalent population of Major Depressive Disorder (MDD) in the 7MM was 34,011,712 in 2017, during the study period [2017–2030].
According to DelveInsight’s analysis, it has been observed that females are more prone to MDD in comparison to males.
Among the European 5 countries, France had the highest prevalent population of Major Depressive Disorder (MDD), followed by Germany and Spain. On the other hand, the United Kingdom had the lowest prevalent population of Major Depressive Disorder (MDD)
Visit For Sample Pages:
Key Benefits of Major Depressive Disorder Market Report
Major Depressive Disorder market report provides an in-depth analysis of Major Depressive Disorder Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Major Depressive Disorder market report will help in developing business strategies by understanding the Major Depressive Disorder Market trends & developments, key players and future market competition that will shape and drive the Major Depressive Disorder market in the upcoming years.
The Major Depressive Disorder market report covers Major Depressive Disorder current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Major Depressive Disorder market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Major Depressive Disorder market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Major Depressive Disorder market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Major Depressive Disorder market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
The Major Depressive Disorder epidemiology section covers insights about historical and current Major Depressive Disorder patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The Major Depressive Disorder Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Major Depressive Disorder market or expected to get launched in the market during the study period. The analysis covers Major Depressive Disorder market uptake by drugs; patient uptake by therapies; and sales of each drug.
Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the emerging drugs in the Major Depressive Disorder (ACC) Market include AXS-05, ALKS 5461, Seltorexant (MIN-202), Esketamine nasal spray, Pimavanserin and others. The key players that are working toward the development of therapies for ACC include-
J&J/ Minerva Neurosciences
Table of Content
1. Key Insights
2. Executive Summary
3. Major Depressive Disorder Competitive Intelligence Analysis
4. Major Depressive Disorder Market Overview at a Glance
5. Major Depressive Disorder Disease Background and Overview
6. Major Depressive Disorder Patient Journey
7. Major Depressive Disorder Epidemiology and Patient Population
8. Major Depressive Disorder Treatment Algorithm, Current Treatment, and Medical Practices
9. Major Depressive Disorder Unmet Needs
10. Key Endpoints of Major Depressive Disorder Treatment
11. Major Depressive Disorder Marketed Products
12. Major Depressive Disorder Emerging Therapies
13. Major Depressive Disorder Seven Major Market Analysis
14. Attribute Analysis
15. Major Depressive Disorder Market Outlook (7 major markets)
16. Major Depressive Disorder Access and Reimbursement Overview
17. KOL Views on the Major Depressive Disorder Market.
18. Major Depressive Disorder Market Drivers
19. Major Depressive Disorder Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Major Depressive Disorder Epidemiology Forecast to 2030
DelveInsight’s Major Depressive Disorder Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Major Depressive Disorder in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Major Depressive Disorder Pipeline Insights, 2020
Major Depressive Disorder Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Major Depressive Disorder market.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States